Table 1 Demographics and clinical characteristics of OTSCC patients
Characteristics | No. of Patients (N = 169), n (%) | No. of Events (N = 35), n (%) |
|---|---|---|
Gender | Â | Â |
 Male | 93 (55) | 19 (54) |
 Female | 76 (45) | 16 (46) |
Age (years) | Â | Â |
 < 69 | 141 (84) | 27 (77) |
 ≥ 69 | 28 (16) | 8 (23) |
Tumor size (cm) | Â | Â |
 < 4.2 | 150 (89) | 26 (74) |
 ≥ 4.2 | 19 (11) | 9 (26) |
TNM stage | Â | Â |
 I–II | 147 (87) | 14 (40) |
 III–IV | 22 (13) | 21 (60) |
Treatment | Â | Â |
 Surgery | 121 (72) | 14 (40) |
 Surgery followed by radiotherapy/chemotherapy | 48 (28) | 21 (60) |
IgG (g/L) | Â | Â |
 < 12.51 | 85 (50) | 23 (66) |
 ≥ 12.51 | 84 (50) | 12 (34) |
IgA (g/L) | Â | Â |
 < 1.97 | 73 (43) | 15 (43) |
 ≥ 1.97 | 96 (57) | 20 (57) |
IgM (g/L) | Â | Â |
 < 1.09 | 78 (46) | 19 (54) |
 ≥ 1.09 | 91 (54) | 16 (46) |
C3 (g/L) | Â | Â |
 < 1.05 | 86 (51) | 15 (43) |
 ≥ 1.05 | 83 (49) | 20 (57) |
C4 (g/L) | Â | Â |
 < 0.22 | 56 (33) | 11 (31) |
 ≥ 0.22 | 113 (67) | 24 (69) |
BF (g/L) | Â | Â |
 < 0.47 | 142 (85) | 29 (83) |
 ≥ 0.47 | 27 (15) | 6 (17) |
CRP (mg/L) | Â | Â |
 < 3.78 | 143 (85) | 28 (80) |
 ≥ 3.78 | 26 (15) | 7 (20) |
WBC (× 109/L) |  |  |
 < 4.95 | 30 (17) | 9 (26) |
 ≥ 4.95 | 139 (83) | 26 (74) |
PLR | Â | Â |
 < 177.86 | 148 (88) | 29 (83) |
 ≥ 177.86 | 21 (12) | 6 (17) |
NLR | Â | Â |
 < 1.61 | 63 (37) | 16 (46) |
 ≥ 1.61 | 106 (63) | 19 (54) |
LMR | Â | Â |
 < 4.15 | 96 (57) | 27 (77) |
 ≥ 4.16 | 73 (43) | 8 (23) |